Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 846

1.

Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.

Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, Metz C, Mangano K, Papaccio G, Al-Abed Y, Nicoletti F.

J Cell Physiol. 2008 Jun;215(3):665-75.

PMID:
18064633
3.

Interleukin-1beta and macrophage migration inhibitory factor (MIF) in dermal fibroblasts mediate UVA-induced matrix metalloproteinase-1 expression.

Honda A, Abe R, Makino T, Norisugi O, Fujita Y, Watanabe H, Nishihira J, Iwakura Y, Yamagishi S, Shimizu H, Shimizu T.

J Dermatol Sci. 2008 Jan;49(1):63-72. Epub 2007 Dec 3.

PMID:
18060744
4.

A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.

Stosic-Grujicic S, Cvetkovic I, Mangano K, Fresta M, Maksimovic-Ivanic D, Harhaji L, Popadic D, Momcilovic M, Miljkovic D, Kim J, Al-Abed Y, Nicoletti F.

J Pharmacol Exp Ther. 2007 Mar;320(3):1038-49. Epub 2006 Dec 5. Erratum in: J Pharmacol Exp Ther. 2007 Apr;321(1):420. Abed, Yousef Al [corrected to Al-Abed, Yousef].

5.

NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.

Yasuda H, Jin Z, Nakayama M, Yamada K, Kishi M, Okumachi Y, Arai T, Moriyama H, Yokono K, Nagata M.

Diabetes Res Clin Pract. 2009 Feb;83(2):200-7. doi: 10.1016/j.diabres.2008.11.029. Epub 2008 Dec 30.

PMID:
19117633
6.

Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice.

Bojunga J, Kusterer K, Bacher M, Kurek R, Usadel KH, Renneberg H.

Cytokine. 2003 Feb 21;21(4):179-86.

PMID:
12788306
7.

Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.

Flodström M, Tyrberg B, Eizirik DL, Sandler S.

Diabetes. 1999 Apr;48(4):706-13.

PMID:
10102685
8.

IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.

Rothe H, Hausmann A, Casteels K, Okamura H, Kurimoto M, Burkart V, Mathieu C, Kolb H.

J Immunol. 1999 Aug 1;163(3):1230-6.

9.

Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.

Cvetkovic I, Al-Abed Y, Miljkovic D, Maksimovic-Ivanic D, Roth J, Bacher M, Lan HY, Nicoletti F, Stosic-Grujicic S.

Endocrinology. 2005 Jul;146(7):2942-51. Epub 2005 Mar 24.

PMID:
15790730
10.

Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes.

Stosic-Grujicic SD, Miljkovic DM, Cvetkovic ID, Maksimovic-Ivanic DD, Trajkovic V.

J Autoimmun. 2004 Jun;22(4):267-76.

PMID:
15120750
12.

Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice.

Ogawa J, Takahashi S, Fujiwara T, Fukushige J, Hosokawa T, Izumi T, Kurakata S, Horikoshi H.

Life Sci. 1999;65(12):1287-96.

PMID:
10503944
14.
15.
16.

Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

J Immunol. 2000 Sep 1;165(5):2841-9.

17.

Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.

Jüttner S, Bernhagen J, Metz CN, Röllinghoff M, Bucala R, Gessner A.

J Immunol. 1998 Sep 1;161(5):2383-90.

18.

Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.

Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J.

Gastroenterology. 2007 Mar;132(3):982-93. Epub 2006 Dec 17.

PMID:
17324399
19.

Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.

Herold KC, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, Brown DR.

J Immunol. 1996 May 1;156(9):3521-7.

PMID:
8617981
20.

Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.

Gerling IC, Friedman H, Greiner DL, Shultz LD, Leiter EH.

Diabetes. 1994 Mar;43(3):433-40.

PMID:
8314017

Supplemental Content

Support Center